Invest now
Windlas Biotech Balance Sheet Annual
BSE: 543329 | NSE: WINDLAS | ISIN: INE0H5O01029 | Sector: Biotechnology & Drugs1,143.00 +15.45 (1.37%)Updated : 11 Sep 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 907.35 | 760.45 | 626.21 | 528.98 |
| Accumulated Depreciation Total | -148.16 | -118.61 | -92.06 | -81.51 |
| Cash Equivalents | 0.48 | 0.21 | 0.15 | 0.06 |
| Other Liabilities Total | 3.33 | 2.98 | 2.50 | 2.34 |
| Accrued Expenses | 32.66 | 34.47 | 30.38 | 25.63 |
| Long Term Debt | 0.10 | 0.00 | 0.00 | 0.11 |
| Common Stock Total | 10.55 | 10.48 | 10.40 | 10.46 |
| Other Equity Total | -0.05 | -0.05 | -0.04 | -0.04 |
| Other Current Assets Total | 0.03 | 0.18 | 24.92 | 26.93 |
| Prepaid Expenses | 1.39 | 1.05 | 0.98 | 1.03 |
| Total Assets | 907.35 | 760.45 | 626.21 | 528.98 |
| Current Portof LT Debt/ Capital Leases | 33.09 | 30.35 | 1.62 | 1.87 |
| Additional Paid- In Capital | 202.91 | 198.94 | 194.60 | 198.62 |
| Cash | 0.51 | 0.42 | 5.27 | 3.69 |
| Total Equity | 580.84 | 505.77 | 449.94 | 402.27 |
| Long Term Investments | 1.75 | 0.97 | 1.98 | 5.82 |
| Retained Earnings( Accumulated Deficit) | 347.76 | 291.15 | 240.09 | 190.41 |
| Total Common Shares Outstanding | 2.11 | 2.10 | 2.08 | 2.09 |
| Property/ Plant/ Equipment Total- Gross | 414.17 | 340.53 | 272.35 | 204.22 |
| Tangible Book Valueper Share Common Eq | 271.92 | 238.08 | 214.18 | 191.52 |
| Total Liabilities | 326.51 | 254.68 | 176.27 | 126.70 |
| Total Debt | 35.34 | 32.60 | 3.64 | 4.99 |
| Short Term Investments | 278.28 | 238.85 | 199.07 | 128.28 |
| Cashand Short Term Investments | 279.28 | 239.48 | 204.49 | 132.02 |
| Total Receivables Net | 281.52 | 201.15 | 137.71 | 117.35 |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Accounts Receivable- Trade Net | 227.83 | 167.45 | 136.94 | 117.30 |
| Property/ Plant/ Equipment Total- Net | 266.01 | 221.93 | 180.29 | 122.70 |
| Total Current Liabilities | 320.93 | 249.44 | 171.75 | 121.24 |
| Total Inventory | 64.63 | 83.27 | 63.18 | 76.20 |
| ESOP Debt Guarantee | 19.66 | 5.25 | 4.89 | 2.82 |
| Accounts Payable | 238.49 | 167.24 | 131.51 | 87.74 |
| Other Currentliabilities Total | 16.68 | 17.39 | 8.24 | 6.01 |
| Total Long Term Debt | 2.25 | 2.25 | 2.02 | 3.13 |
| Intangibles Net | 6.91 | 6.78 | 4.47 | 1.48 |
| Other Long Term Assets Total | 4.98 | 3.70 | 2.96 | 3.94 |
| Note Receivable- Long Term | 0.85 | 1.94 | 5.22 | 41.49 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 626.85 | 525.13 | 431.29 | 353.54 |
| Capital Lease Obligations | 2.15 | 2.25 | 2.02 | 3.02 |
*All figures in crores except per share values
Windlas Biotech Quick Links
Windlas Biotech Dividend Windlas Biotech Bonus Windlas Biotech News Windlas Biotech AGM Windlas Biotech Rights Windlas Biotech Splits Windlas Biotech Board Meetings Windlas Biotech Key Metrics Windlas Biotech Shareholdings Windlas Biotech Profit Loss Windlas Biotech Cashflow Windlas Biotech Q1 Results Windlas Biotech Q2 Results Windlas Biotech Q3 Results Windlas Biotech Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
272.00+6.05(2.27%)
1,260.00+20.50(1.65%)
11,053.00+157.00(1.44%)
1,196.80-29.75 (-2.43%)
185.95-2.60 (-1.38%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.